Hudson Bay Capital Management’s Gilead Sciences GILD Stock Holding History

Hudson Bay Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-415,000	Closed	-$46.1M	–	1317
2025 Q3	$46.1M	Buy	415,000 +405,700	+4,362%	+$46.1M	0.15%	112
2025 Q2	$1.03M	Sell	9,300 -43,400	-82%	-$4.62M	﹤0.01%	956
2025 Q1	$5.91M	Buy	+52,700	New	+$5.44M	0.02%	552
2019 Q4	–	Sell	-40,000	Closed	-$2.54M	–	453
2019 Q3	$2.54M	Hold	40,000	–	–	0.07%	231
2019 Q2	$2.7M	Sell	40,000 -35,000	-47%	-$2.3M	0.06%	242
2019 Q1	$4.88M	Buy	75,000 +5,000	+7%	+$332K	0.06%	283
2018 Q4	$4.38M	Buy	70,000 +40,000	+133%	+$2.8M	0.06%	334
2018 Q3	$2.32M	Sell	30,000 -55,000	-65%	-$4.15M	0.03%	434
2018 Q2	$6.02M	Buy	+85,000	New	+$6M	0.08%	236
2017 Q2	–	Sell	-50,000	Closed	-$3.4M	–	632
2017 Q1	$3.4M	Buy	+50,000	New	+$3.52M	0.05%	348

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Hudson Bay Capital Management's GILD Position: Q1 2026 in Review

Hudson Bay Capital Management reduced its Gilead Sciences (GILD) stake by 27% in Q1 2026, selling an estimated $5.16M and leaving 100,010 shares worth $13.9M. The position accounts for 0.05% of the portfolio, ranked #247.

Hudson Bay Capital Management first reported a position in GILD in Q2 2014 and has held it in 24 quarters since. The position peaked at $34.7M in Q1 2024. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Hudson Bay Capital Management held 100,010 shares of Gilead Sciences worth $13.9M as of Q1 2026.
Hudson Bay Capital Management sold 36,861 Gilead Sciences shares in Q1 2026, an estimated $5.16M.
Gilead Sciences made up 0.05% of Hudson Bay Capital Management's portfolio in Q1 2026, its #247 holding.
Hudson Bay Capital Management first reported a position in Gilead Sciences in Q2 2014 and has held it in 24 quarters since.
Hudson Bay Capital Management's Gilead Sciences position peaked at $34.7M in Q1 2024.
2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.